Target intelligence / Profile preview

Nuclear factor kappa B DNA consensus sequence (NF-κB consensus sequence) (NF-κB consensus sequence)

Target
NF-κB consensus sequence
Molecular classification
Transcription factor binding site, Regulatory element, DNA sequence
01

Overview

The Nuclear factor kappa B (NF-κB) DNA consensus sequence is a specific 10-base pair genomic motif, typically represented as 5'-GGGRNNYYCC-3', found in the regulatory regions of genes involved in immunity and cell survival (Source: PubMed ID: 11244031). This sequence acts as the primary binding site for NF-κB transcription factor dimers, which are activated in response to stimuli like TNF-alpha, IL-1, or lipopolysaccharides (Source: Wikipedia). Once bound, NF-κB triggers the expression of a wide array of genes that drive inflammation, immune cell activation, and anti-apoptotic pathways (Source: Nat Rev Immunol). In many diseases, including chronic inflammation and cancer, the interaction between NF-κB and these DNA sequences is pathologically upregulated, leading to tissue damage or tumor progression (Source: NIH). Therapeutic intervention targeting these sequences often employs "decoy" oligonucleotides—synthetic DNA fragments that mimic the consensus sequence to sequester NF-κB proteins and prevent them from reaching the genome (Source: PubMed ID: 15123778). This strategy effectively silences the transcription of pro-inflammatory and pro-survival genes, offering a targeted approach to treating conditions like atopic dermatitis and rheumatoid arthritis (Source: AnGes MG).

Other names
κB siteNF-kappaB binding siteNF-κB response elementNFKB consensus sequenceNF-kappaB DNA binding motif
02

Mechanism of action

Competitive inhibition of transcription factor binding via decoy oligonucleotides

03

Biological functions

Regulation of transcriptionImmune responseInflammatory responseCell survivalApoptosis regulation
04

Disease associations

InflammationCancerAutoimmune diseaseAtopic dermatitisRheumatoid arthritisAsthma
05

Safety considerations

Systemic immunosuppressionOff-target DNA bindingOligonucleotide stability in vivoInnate immune activation via TLR9
06

Interacting drugs

NF-κB decoy oligonucleotide

2 more in the full profile.

07

Biomarkers

NF-κB p65 nuclear translocationInterleukin-6 (IL-6) levelsTumor necrosis factor-alpha (TNF-alpha) levelsC-reactive protein (CRP)ICAM-1 expression

Beyond the preview

Go deeper on Nuclear factor kappa B DNA consensus sequence (NF-κB consensus sequence) (NF-κB consensus sequence).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear factor kappa B DNA consensus sequence (NF-κB consensus sequence) (NF-κB consensus sequence).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call